05/29/2022 | Press release | Distributed by Public on 05/29/2022 00:56

Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal Function in Fabry Disease - 24-Month Results from the Phase III Randomized, Double-blind, BALANCE Study;[...]

Please select the service you want to use:

• Newsvine
• Digg
• Delicious
• StumbleUpon
• Technorati
• Buzz
• Favorites
• Google Reader

 Back

 Download the original document